Literature DB >> 4345903

Immunological studies in Ugandan patients with hepatocellular carcinoma.

A Primack, C L Vogel, L F Barker.   

Abstract

Immunological studies were performed on Ugandan patients with hepatocellular carcinoma to test the hypothesis that the high rate of persistence of hepatitis-associated antigen in these patients is the result of defects in host immune response. The responses to 1-chloro-2,4-dinitrobenzene sensitization and to a battery of recall skin test antigens were normal, as was the humoral antibody response to tularaemia antigen. Neither hypogammaglobulinaemia nor specific immunoglobulin deficiencies were found. Thus it appears unlikely that generalized defects in host immune responses can account for the high incidence of persistent hepatitis B virus infection found in Ugandan patients with hepatocellular carcinoma.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4345903      PMCID: PMC1588577          DOI: 10.1136/bmj.1.5844.16

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  22 in total

1.  Familial hepatoma with hepatitis-associated antigen.

Authors:  E K Denison; R L Peters; T B Reynolds
Journal:  Ann Intern Med       Date:  1971-03       Impact factor: 25.391

2.  Hepatitis-associated antigen and hepatocellular carcinoma.

Authors:  J Terés; J Guardia; M Bruguera; J Rodes
Journal:  Lancet       Date:  1971-07-24       Impact factor: 79.321

3.  Chronic liver disease and primary liver-cell cancer with hepatitis-associated (Australia) antigen in serum.

Authors:  S Sherlock; R A Fox; S P Niazi; P J Scheuer
Journal:  Lancet       Date:  1970-06-13       Impact factor: 79.321

4.  Hepatitis-associated antigen in chronic liver disease.

Authors:  S J Hadziyannis; G E Merikas; A P Afroudakis
Journal:  Lancet       Date:  1970-07-11       Impact factor: 79.321

5.  S.H. antigen and chronic liver disease.

Authors:  A M Prince; L Leblanc; K Krohn; R Masseyeff; M E Alpert
Journal:  Lancet       Date:  1970-10-03       Impact factor: 79.321

6.  Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma.

Authors:  C L Vogel; P P Anthony; N Mody; L F Barker
Journal:  Lancet       Date:  1970-09-26       Impact factor: 79.321

7.  Viral hepatitis, postnecrotic cirrhosis, and hepatocellular carcinoma.

Authors:  J B Smith; B S Blumberg
Journal:  Lancet       Date:  1969-11-01       Impact factor: 79.321

8.  Rapid detection of Australia antigen by counterimmunoelectrophoresis.

Authors:  D J Gocke; C Howe
Journal:  J Immunol       Date:  1970-04       Impact factor: 5.422

9.  Hepatitis and Australia antigen: autosomal recessive inheritance of susceptibility to infection in humans.

Authors:  B S Blumberg; J S Friedlaender; A Woodside; A I Sutnick; W T London
Journal:  Proc Natl Acad Sci U S A       Date:  1969-04       Impact factor: 11.205

10.  Immunologic studies in patients with malignant melanoma in Uganda.

Authors:  J L Ziegler; M G Lewis; J M Luyombya; J W Kiryabwire
Journal:  Br J Cancer       Date:  1969-12       Impact factor: 7.640

View more
  5 in total

Review 1.  Primary liver cancer and its relationship to chronic infection with the hepatitis B virus.

Authors:  S J Hadziyannis
Journal:  Springer Semin Immunopathol       Date:  1981-04

Review 2.  Cellular and molecular targets for the immunotherapy of hepatocellular carcinoma.

Authors:  Vikrant Rai; Joe Abdo; Abdullah N Alsuwaidan; Swati Agrawal; Poonam Sharma; Devendra K Agrawal
Journal:  Mol Cell Biochem       Date:  2017-06-07       Impact factor: 3.842

3.  Serum immunoglobulin levels in primary liver cancer: relationship to underlying cirrhosis and hepatitis-B (surface) antigenaemia.

Authors:  T Ipp; G M Macnab; E W Geddes; M C Kew
Journal:  Br J Cancer       Date:  1975-10       Impact factor: 7.640

4.  Hepatitis-B surface antigen and antibody in Bantu patients with primary hepatocellular cancer.

Authors:  G M Macnab; J M Urbanowicz; E W Geddes; M C Kew
Journal:  Br J Cancer       Date:  1976-05       Impact factor: 7.640

5.  Tropical cirrhosis and hepatoma.

Authors:  A Coady
Journal:  J R Coll Physicians Lond       Date:  1976-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.